These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

976 related articles for article (PubMed ID: 22311171)

  • 1. Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.
    Hogardt M; Heesemann J
    Curr Top Microbiol Immunol; 2013; 358():91-118. PubMed ID: 22311171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung.
    Hogardt M; Heesemann J
    Int J Med Microbiol; 2010 Dec; 300(8):557-62. PubMed ID: 20943439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis.
    Hoboth C; Hoffmann R; Eichner A; Henke C; Schmoldt S; Imhof A; Heesemann J; Hogardt M
    J Infect Dis; 2009 Jul; 200(1):118-30. PubMed ID: 19459782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants.
    Ciofu O; Mandsberg LF; Bjarnsholt T; Wassermann T; Høiby N
    Microbiology (Reading); 2010 Apr; 156(Pt 4):1108-1119. PubMed ID: 20019078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Marker genes for the metabolic adaptation of Pseudomonas aeruginosa to the hypoxic cystic fibrosis lung environment.
    Eichner A; Günther N; Arnold M; Schobert M; Heesemann J; Hogardt M
    Int J Med Microbiol; 2014 Nov; 304(8):1050-61. PubMed ID: 25130702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infections.
    Feliziani S; Luján AM; Moyano AJ; Sola C; Bocco JL; Montanaro P; Canigia LF; Argaraña CE; Smania AM
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20844762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis.
    Hogardt M; Hoboth C; Schmoldt S; Henke C; Bader L; Heesemann J
    J Infect Dis; 2007 Jan; 195(1):70-80. PubMed ID: 17152010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid diversification of
    Schick A; Kassen R
    Proc Natl Acad Sci U S A; 2018 Oct; 115(42):10714-10719. PubMed ID: 30275334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic pressure compensates the biological cost associated with Pseudomonas aeruginosa hypermutable phenotypes in vitro and in a murine model of chronic airways infection.
    Alcalá-Franco B; Montanari S; Cigana C; Bertoni G; Oliver A; Bragonzi A
    J Antimicrob Chemother; 2012 Apr; 67(4):962-9. PubMed ID: 22294647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa microevolution during cystic fibrosis lung infection establishes clones with adapted virulence.
    Bragonzi A; Paroni M; Nonis A; Cramer N; Montanari S; Rejman J; Di Serio C; Döring G; Tümmler B
    Am J Respir Crit Care Med; 2009 Jul; 180(2):138-45. PubMed ID: 19423715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cystic fibrosis-niche adaptation of Pseudomonas aeruginosa reduces virulence in multiple infection hosts.
    Lorè NI; Cigana C; De Fino I; Riva C; Juhas M; Schwager S; Eberl L; Bragonzi A
    PLoS One; 2012; 7(4):e35648. PubMed ID: 22558188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
    Sousa AM; Monteiro R; Pereira MO
    Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation.
    Ciofu O; Riis B; Pressler T; Poulsen HE; Høiby N
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2276-82. PubMed ID: 15917521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-Term Microevolution of Pseudomonas aeruginosa Differs between Mildly and Severely Affected Cystic Fibrosis Lungs.
    Klockgether J; Cramer N; Fischer S; Wiehlmann L; Tümmler B
    Am J Respir Cell Mol Biol; 2018 Aug; 59(2):246-256. PubMed ID: 29470920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa.
    Williams HD; Zlosnik JE; Ryall B
    Adv Microb Physiol; 2007; 52():1-71. PubMed ID: 17027370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology and dynamics of Pseudomonas aeruginosa populations in lungs of cystic fibrosis patients.
    Jelsbak L; Johansen HK; Frost AL; Thøgersen R; Thomsen LE; Ciofu O; Yang L; Haagensen JA; Høiby N; Molin S
    Infect Immun; 2007 May; 75(5):2214-24. PubMed ID: 17261614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LasR Variant Cystic Fibrosis Isolates Reveal an Adaptable Quorum-Sensing Hierarchy in Pseudomonas aeruginosa.
    Feltner JB; Wolter DJ; Pope CE; Groleau MC; Smalley NE; Greenberg EP; Mayer-Hamblett N; Burns J; Déziel E; Hoffman LR; Dandekar AA
    mBio; 2016 Oct; 7(5):. PubMed ID: 27703072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro evolution of Pseudomonas aeruginosa AA2 biofilms in the presence of cystic fibrosis lung microbiome members.
    Vandeplassche E; Sass A; Lemarcq A; Dandekar AA; Coenye T; Crabbé A
    Sci Rep; 2019 Sep; 9(1):12859. PubMed ID: 31492943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.